Lilburn, GA, United States of America

Charles D Humphrey

This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2007-2010.


Average Co-Inventor Count = 24.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Charles D. Humphrey: Innovator in Coronavirus Research

Introduction

Charles D. Humphrey is a notable inventor based in Lilburn, GA (US). He has made significant contributions to the field of virology, particularly in the study of coronaviruses. With a total of 2 patents, his work has been instrumental in advancing our understanding of severe acute respiratory syndrome (SARS).

Latest Patents

Humphrey's latest patents focus on a newly isolated human coronavirus, specifically SARS-CoV, which is the causative agent of SARS. The patents disclose the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames. Additionally, they provide methods for detecting SARS-CoV and infections associated with it. Immune stimulatory compositions are also included, along with methods for their use.

Career Highlights

Charles D. Humphrey works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His research has contributed to the development of diagnostic tools and therapeutic strategies for combating coronavirus infections.

Collaborations

Some of his notable coworkers include Paul A. Rota and Larry J. Anderson. Their collaborative efforts have furthered research in the field of infectious diseases.

Conclusion

Charles D. Humphrey's innovative work in coronavirus research has made a lasting impact on public health. His patents and collaborations continue to play a crucial role in the fight against viral infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…